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Abstract
Borrelia burgdorferi sensu lato (Bbsl), the causative agent of Lyme disease, establishes an
initial infection in the host’s skin following a tick bite, and then disseminates to distant
organs, leading to multisystem manifestations. Tick-to-vertebrate host transmission
requires that Bbsl survives during blood feeding. Complement is an important innate host
defense in blood and interstitial fluid. Bbsl produces a polymorphic surface protein, CspA,
that binds to a complement regulator, Factor H (FH) to block complement activation in vitro.
However, the role that CspA plays in the Bbsl enzootic cycle remains unclear. In this study,
we demonstrated that different CspA variants promote spirochete binding to FH to inactivate
complement and promote serum resistance in a host-specific manner. Utilizing a tick-to-
mouse transmission model, we observed that a cspA-knockout B. burgdorferi is eliminated
from nymphal ticks in the first 24 hours of feeding and is unable to be transmitted to naïve
mice. Conversely, ectopically producing CspA derived from B. burgdorferi or B. afzelii, but
not B. garinii in a cspA-knockout strain restored spirochete survival in fed nymphs and tick-
to-mouse transmission. Furthermore, a CspA point mutant, CspA-L246D that was defective
in FH-binding, failed to survive in fed nymphs and at the inoculation site or bloodstream in
mice. We also allowed those spirochete-infected nymphs to feed on C3-/- mice that lacked
functional complement. The cspA-knockout B. burgdorferi or this mutant strain comple-
mented with cspA variants or cspA-L246D was found at similar levels as wild type B. burg-
dorferi in the fed nymphs and mouse tissues. These novel findings suggest that the FH-
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binding activity of CspA protects spirochetes from complement-mediated killing in fed
nymphal ticks, which ultimately allows Bbsl transmission to mammalian hosts.
Author summary
Lyme disease, the most common vector-borne disease in the United States, is caused by
the bacterium, Borrelia burgdorferi. This bacterium is transmitted to humans via the bite
of a tick, and then spreads from the bite site to multiple tissues. Tick-to-human transmis-
sion of this bacterium requires bacterial survival in fed ticks because the blood and body
fluid that ticks consume contain complement, an important mechanism that kills bacteria.
To prevent host cell damage by this powerful mechanism, vertebrate animals produce fac-
tor H to inhibit complement. Lyme disease bacteria produce a surface protein CspA that
binds to factor H to inhibit complement, but the role that CspA-mediated factor H-bind-
ing activity plays in tick-to-human transmission remains unexplained. To investigate this,
we infected mice with Lyme disease strains that were identical except for the CspA variant
or mutant with no factor H-binding ability they produced. We found that the factor H-
binding activity of CspA appears to prevent the bacteria from being killed by complement
in fed nymphal ticks. Such ability further facilitates bacterial transmission to mice. These
results will promote the development of strategies against CspA to intervene in Lyme dis-
ease bacterial transmission from ticks to humans.
Introduction
Lyme disease is caused by spirochetes of Bbsl and is transmitted to humans by the bites of
infected Ixodes ticks. It is the most common vector-borne disease in North America and
Europe [1, 2]. Upon blood feeding, spirochetes migrate from the ticks’ midguts to salivary
glands, where they are transmitted to the host’s skin at the tick bite sites [2, 3]. In humans,
Lyme borreliae initiate local skin infection often leading to erythema migrans, commonly
known as a “bull’s-eye” rash [1, 2]. If left untreated, spirochetes are capable of entering the
bloodstream and spreading to multiple tissues and organs, leading to arthritis, carditis, neuro-
borreliosis, and acrodermatitis chronica atrophicans [4]. The three main Lyme disease causing
species, B. afzelii, B. garinii, and B. burgdorferi sensu stricto (hereafter B. burgdorferi), survive
not only in humans, but also in other vertebrate animals [5]. These spirochete species tend to
be associated with different vertebrate hosts: B. afzelii is typically isolated from small mam-
mals, B. garinii from birds, and B. burgdorferi from both hosts [6, 7]. Specific spirochete-host
associations are thought to be caused by the selective ability of these spirochetes to evade
innate immune responses of different hosts. One such immune response, complement, is the
first-line defense mechanism in humans and other vertebrates [7, 8].
The fluid-phase of complement is comprised of serum proteins, which are sequentially acti-
vated in response to invading pathogens [9, 10]. Complement can be initiated by three differ-
ent pathways (the classical, alternative, and lectin pathways) which result in the formation of
two distinct C3 convertases, C4b2a and C3bBb [11]. These C3 convertases recruit other com-
plement components to generate C5 convertases, resulting in the release of pro-inflammatory
peptides (C3a and C5a), the deposition of opsonins (C3b and iC3b) on microbial surfaces, and
in the case of gram-negative organisms, lysis via insertion of the pore-forming membrane
attack complex (C5b-9 also known as MAC) [11]. Humans and other vertebrates produce
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complement regulators to down-regulate the excessive complement activity to prevent host
cell damage from non-specific attack by complement [9]. For example, factor H (FH) and fac-
tor H-like protein-1 (FHL-1, the spliced form of FH [12]) bind to C3b to promote its cleavage
to iC3b, which is hemolytically inactive [9]. Interestingly, FH sequences from different verte-
brate animals are diverse (e.g. 60 to 70% identity between mice and humans), suggesting a
selective adaptation of FH to efficiently regulate the host-specific complement [13, 14].
Invading pathogens produce a variety of surface components such as capsules, lipopolysac-
charides (e.g., O-antigens), and complement regulator-binding proteins to combat comple-
ment-mediated killing [15–18]. These complement regulator-binding proteins recruit these
complement regulators to promote pathogen survival in the blood or serum (also known as
serum resistance) [19, 20]. Like other pathogens, Lyme borreliae produce surface proteins that
bind complement regulators to block the formation of lethal pores generated by the MAC. The
resulting localization (and hence locally high concentration) of complement regulators on the
spirochete surface permits survival of Lyme borreliae despite high concentrations of comple-
ment in the blood [21, 22]. B. burgdorferi produces five complement regulator acquiring sur-
face proteins (CRASPs) including CspA (CRASP-1), CspZ (CRASP-2), ErpP (CRASP-3),
ErpC (CRASP-4), and ErpA (CRASP-5) [23]. These CRASP proteins share activities in binding
to FH (for all 5 CRASPs) and FHL-1 (for CspA and CspZ) [23] and degrading C3 or C5 con-
vertases by binding to plasminogen (for all 5 CRASPs) [24, 25]. Additionally, CspA also inhib-
its complement by binding to C7 and C9 to block the formation of MAC [24, 25]. Unlike other
CRASP genes, cspA is expressed when Lyme borreliae are in both fed and unfed nymphal ticks
or at the inoculation site immediately after infection, suggesting that CspA may play a unique
role in tick-to-mammal transmission [26, 27]. Ectopic production of CspA confers resistance
to human serum in an in vitro gain-of-function study [24, 25], while deleting cspA from an
infectious and serum-resistant B. burgdorferi strain makes this strain susceptible in human
serum in vitro [28, 29]. These results indicate that CspA functions as a key factor to promote
spirochete survival in serum.
CspA is highly conserved within B. burgdorferi (greater than 90% identity) but displays less
than 50% sequence identity across different spirochete species [25]. Consistent with this varia-
tion, CspA variants from B. burgdorferi, B. spielmannii, or B. afzelii exhibit varying capacities
to bind human FH and differ in their abilities to resist human serum [25, 30, 31]. These find-
ings led us to hypothesize that the CspA-mediated FH-binding activity promotes spirochete
serum survival in a vertebrate animal-specific manner. In addition, while the role that CspA
plays in vitro has been extensively characterized, the function of this protein for Lyme borreliae
in the enzootic cycle is still unclear. In this study, we elucidate the role of CspA-FH interac-
tions in promoting complement evasion in vitro and tick-to-host transmission of Lyme
borreliae.
Results
Polymorphic CspA variants have differential binding affinities to factor H
from different vertebrate animals
The sequences of CspA variants among B. burgdorferi sensu lato are extremely polymorphic
(S1 Fig) [25]. We thus sought to examine whether CspA polymorphisms account for variant-
to-variant differences in their abilities to bind to FH from different vertebrate species. Thus,
we tested the ability of recombinant CspA proteins derived from cspA sequences of B. burgdor-
feri strain B31 (CspAB31), B. afzelii strain PKo (CspAPKo), or B. garinii strain ZQ1 (CspAZQ1)
to bind to FH from different vertebrate animals. These animals include mouse (Mus musculus),
Coturnix quail (rodent or avian model of Lyme disease [32, 33]), human (incidental host), and
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horse (dead-end host). We used ELISA and surface plasmon resonance (SPR) to evaluate the
FH-binding affinity of CspA variants. A CspA mutant, CspAB31L246D, in which the leucine at
position 246 was replaced by aspartic acid rendering it incapable of binding to human FH [34,
35], was included as negative control. As expected, while the irrelevant negative control pro-
tein B. burgdorferi DbpA did not bind to FH from these animals, both methods for assessing
binding affinity indicated three distinct binding patterns of CspA variants in a host-specific
manner (S2 and S3 Figs, and Table 1): (1) CspAB31 exhibited a versatile binding pattern to FH
from all tested species (ELISA: KD = 0.23–0.92 μM, SPR: KD = 0.07–0.55 μM); (2) CspAPKo
possessed less flexible binding, with preference for human and mouse FH (ELISA: KD = 0.16–
0.76 μM, SPR: KD = 0.11–0.46 μM), but not horse or quail FH; (3) CspAZQ1 bound only to FH
from quail (ELISA: KD = 0.36 μM). As expected, the recombinant CspAB31L246D, which
retained a secondary structure similar to wild type CspAB31 by far-UV CD analysis (S1 and S4
Figs and S1 Table), was unable to bind to FH from any of the tested species (S2 and S3 Figs
and Table 1). These results indicate that CspA variants from different Lyme borreliae species
bind variably to FH from different animals, and that leucine-246 of CspAB31 is essential for its
ability to bind to FH from all tested animals.
Table 1. CspA variants differ in binding to factor H from different animals.
CspA variant Factor H source ELISA KD (μM)b - - - - -Surface Plasmon Resonance- - - -
KD (μM)a kon (105s-1M-1) koff (s-1)
B. burgdorferi
CspAB31 Human 0.41±0.09 0.20±0.07 1.14±0.42 0.017±0.005
Mouse 0.23±0.08 0.07±0.01 1.88±0.36 0.012±0.005
Horse 0.88±0.33 0.55±0.18 0.30±0.01 0.014±0.003
Quail 0.92±0.28 n.d.a n.d. n.d.
CspAB31L246D Human n.s.
b n.b. n.b. n.b.
Mouse n.s. n.b. n.b. n.b.
Horse n.b.c n.b. n.b. n.b.
Quail n.b. n.d. n.d. n.d.
DbpAB31
d Human n.b. n.d. n.d. n.d.
Mouse n.b. n.d. n.d. n.d.
Horse n.b. n.d. n.d. n.d.
Quail n.b. n.d. n.d. n.d.
B. afzelii
CspAPko Human 0.16±0.05 0.11±0.02 1.52±0.62 0.014±0.004
Mouse 0.76±0.64 0.46±0.14 1.15±0.31 0.048±0.011
Horse n.b. n.b. n.b. n.b.
Quail n.b. n.d. n.d. n.d.
B. garinii
CspAZQ1 Human n.b. n.b. n.b. n.b.
Mouse n.b. n.b. n.b. n.b.
Horse n.b. n.b. n.b. n.b.
Quail 0.36±0.13 n.d. n.d. n.d.
All values represent the mean ± SEM of three experiments.
aNot determined.
bNot saturated
cNo binding activity was detected.
dDbpAB31 was included as a negative control.
https://doi.org/10.1371/journal.ppat.1007106.t001
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Allelic variable CspA promotes spirochete binding to FH in a host-specific
manner
To examine whether the FH-binding characteristics of CspA proteins described above are
maintained when these variants are produced on the surface of the spirochetes, we trans-
formed shuttle plasmids encoding cspAB31, cspAPKo, cspAZQ1, or cspAB31L246D under the con-
trol of the cspA promoter from B. burgdorferi strain B31 into B. burgdorferi strain B31-
5A4NP1ΔcspA (5A4NP1ΔcspA), a cspA deficient strain previously generated from an infectious
background B. burgdorferi strain B31-5A4NP1 (S2 Table) [28]. Because strain 5A4NP1ΔcspA
was identified to have lost the plasmid lp21, B. burgdorferi strain B31-5A15 (B31-5A15), which
has the same plasmid profile as strain 5A4NP1ΔcspA and is fully virulent, was used as a wild
type (WT) positive control [28, 36]. We first used flow cytometry analysis to verify that the
CspA variants or mutants produced in strain 5A4NP1ΔcspA are localized on the surface of spi-
rochetes and at levels similar to the WT strain B31-5A15 (Fig 1).
We then incubated each of the CspA-producing 5A4NP1ΔcspA-derived strains, strain
5A4NP1ΔcspA harboring the vector alone (hereafter termed 5A4NP1ΔcspA-V), or the WT
strain B31-5A15, with FH purified from human, mouse, horse, or quail. We then determined
their FH-binding activity using flow cytometry. A high passage and non-infectious B. burgdor-
feri strain B313 (B313) harboring the shuttle vector alone was also included as a negative con-
trol as this strain does not encode cspA and does not bind human FH [37]. Consistent with
previous findings [37], strain B313 (vector alone) did not bind human FH (Fig 2A right panel),
or to FH from mouse, horse, and quail (Fig 2B to 2D right panel). The WT strain B31-5A15
bound FH from all these animals (Fig 2A to 2D right panel), in agreement with findings in pre-
vious studies [21, 28]. Strain 5A4NP1ΔcspA-V displayed undetectable levels of human FH-
Fig 1. Localization of CspA on the surface of B. burgdorferi. Flow cytometry analysis of CspA localized on the surface of B. burgdorferi strains B31-
5A15 (“B31-5A15”), B31-5A4NP1ΔcspA harboring the vector pBSV2G (“ΔcspA/Vector”), or this cspA mutant strain producing CspAB31 (“ΔcspA/
pCspAB31”), CspAPKo (“ΔcspA/pCspAPKo”), CspAZQ1 (“ΔcspA/pCspAZQ1”), or CspAB31L246D (“ΔcspA/pCspAB31L246D”). (A) Representative
histograms of flow cytometry analysis showing the levels of CspA surface production to indicated B. burgdorferi strains. (B) The production of CspA
and FlaB (negative control) on the surface of indicated B. burgdorferi strains was detected by flow cytometry (see Materials and methods). Values are
shown relative to the production levels of CspA or FlaB on the surface of permeabilized B. burgdorferi strain B31-5A15. Each bar represents the mean of
four independent determinations ± the standard deviation. (): indicates that relative surface production of the indicated proteins was significantly
lower (P< 0.05 by one-way ANOVA with post hoc Bonferroni correction) than that of CspA or FlaB by B. burgdorferi strain B31-5A15.
https://doi.org/10.1371/journal.ppat.1007106.g001
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binding activity (Fig 2A), similar to previous observations [28]. Note that the infectious B.
burgdorferi strain B31, the background strain of 5A4NP1ΔcspA-V, produces other human FH-
binding proteins when cultivated in vitro [23, 26, 38]. However, these FH-binding proteins are
either produced in extremely low levels [26] or display lower levels of FH-binding ability, com-
pared to CspA [28, 39, 40]. These previous studies support our finding that nearly no human
Fig 2. CspA variants differ in their ability in promoting spirochetes binding to FH from different vertebrate animals. B. burgdorferi strain B31-
5A15 (“B31-5A15”), B31-5A4NP1ΔcspA harboring the vector pBSV2G (“ΔcspA/Vector”), or this cspA mutant strain producing CspAB31 (“ΔcspA/
pCspAB31”), CspAPKo (“ΔcspA/pCspAPKo”), CspAZQ1 (“ΔcspA/pCspAZQ1”), or CspAB31L246D (“ΔcspA/pCspAB31L246D”), or B313 carrying the vector
pBSV2G (“B313/Vector”, negative control) was incubated with FH from human, mouse, horse, or quail. The bacteria were stained with a sheep anti-FH
polyclonal IgG (for the spirochetes incubated with human, mouse, or horse FH) or a mouse anti-FH monoclonal antibody VIG8 (for the spirochetes
incubated with quail FH) followed by an Alexa 647-conjugated donkey anti-sheep IgG or goat anti-mouse IgG prior to being applied to flow cytometry
analysis. (Left panel) Representative histograms of flow cytometry analysis showing the levels of FH from (A) human, (B) mouse, (C) horse, or (D)
quail binding to indicated B. burgdorferi strains. (Right panel) The levels of B. burgdorferi binding to FH from (A) human, (B) mouse, (C) horse, or (D)
quail were measured by flow cytometry and presented as mean fluorescence index (MFI). Each bar represents the mean of three independent
determinations ± SEM. Significant differences (P< 0.05 by one-way ANOVA with post hoc Bonferroni correction) in the levels of FH binding relative
to the B313/Vector (“”) or between two strains relative to each other (“#”).
https://doi.org/10.1371/journal.ppat.1007106.g002
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FH-binding activity was observed in this strain. Additionally, strain 5A4NP1ΔcspA-V did not
show binding ability to mouse, horse, or quail FH (Fig 2B to 2D). These data indicate that
CspA is essential for this infectious B. burgdorferi strain to bind to FH from all tested animals.
Further, expression of CspA variants in strain 5A4NP1ΔcspA restores the levels of binding
to FH in a host-specific manner, reflecting the results obtained with the recombinant proteins
(Fig 2): (1) The production of CspAB31 restored binding to FH from human, mouse, horse,
and quail; (2) CspAPKo increased binding to human and mouse FH but not to horse or quail
FH; (3) CspAZQ1 promoted binding only to quail FH but not to FH from other animals. Addi-
tionally, the cspAB31L246D-complemented strain showed no detectable binding to FH from all
four animals tested (Fig 2A to 2D right panel). We also incubated the above-mentioned spiro-
chete strains with C3-depleted human or mouse serum (C3-depleted horse or quail serum is
not available) to verify the FH-binding activity in the context of serum components.
C3-depleted serum was used because the strains that show reduced FH-binding would have
greater levels of C3b deposited on their surfaces [28], which in turn would bind FH thereby
confounding interpretation of results. We observed binding of human and mouse FH in C3
depleted sera as with purified FH (S5 Fig). These results indicate that the leucine-246 of this
protein plays an essential role in facilitating spirochete binding to FH from these animals.
Species to species variation of CspA-mediated FH binding contributes to
different levels of complement deposition on the spirochete surface
We next aimed to determine the role of host-specific FH-binding of CspA variants in inhibit-
ing complement deposition on the spirochete surface. We first incubated human, mouse, or
horse serum with strain 5A4NP1ΔcspA-V or this strain producing CspAB31, CspAPKo,
CspAZQ1, or CspAB31L246D as well as the WT strain B31-5A15 or the negative control strain
B313. The levels of C3 fragments (C3b and iC3b) and the MAC bound by spirochetes were
quantified using flow cytometry. Quail serum was not included as antibodies against quail C3b
or MAC were not available. FH-depleted serum was not used as the lack of FH in serum causes
an uncontrollable complement activation, which consumes C3 resulting in no C3b/iC3b depo-
sition on spirochete surface [41]. Consistent with previous observations [42], a significant
amount of C3b and MAC was detected on the surface of the strain B313 carrying vector alone
upon incubation with human (Fig 3B and 3D top panel), mouse, or horse serum (Fig 3B and
3D middle and bottom panels). Conversely, incubation of the WT strain B31-5A15 with
serum from these animals resulted in at least 2-fold reduction of C3b deposition compared to
strain B313, and virtually undetectable MAC deposition (Fig 3B and 3D, p< 0.05). Strain
5A4NP1ΔcspA-V had similar levels of C3b and MAC deposition compared to strain B313
(Fig 3B and 3D p> 0.05)[28]. These results indicate that CspA is required to inhibit human
and non-human complement bound to the spirochete surface.
We also observed a correlation between the origin of the serum and the ability of CspA var-
iants to inhibit deposition of C3 fragment or MAC: (1) Compared to strain 5A4NP1ΔcspA-V,
expression of cspAB31 significantly decreased levels of C3b and MAC deposition on the spiro-
chete surface in human serum (Fig 3B and 3D top panels, consistent with a previous finding
[25]) and in mouse or horse sera (Fig 3A and 3C, the middle and bottom panels of Fig 3B and
3D). (2) Expression of cspAPKo in the strain 5A4NP1ΔcspA significantly reduced human and
mouse C3b and MAC deposition compared to strain 5A4NP1ΔcspA-V (Fig 3A and 3C, top
and middle panels of Fig 3B and 3D), in agreement with a previous observation [25], but not
in horse serum (bottom panels of Fig 3B and 3D). (3) Expression of cspAZQ1 resulted in similar
C3b and MAC deposition as the strain 5A4NP1ΔcspA-V in all three sera (Fig 3A to 3D). We
also compared the complement activating abilities of isogenic 5A4NP1ΔcspA producing either
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Fig 3. CspA variants differ in their ability to reduce the deposition of C3b or MAC from different vertebrate animals on the spirochete surface. B.
burgdorferi strain B31-5A15 (“B31-5A15”), B31-5A4NP1ΔcspA harboring the vector pBSV2G (“ΔcspA/Vector”), or this cspA mutant strain producing
CspAB31 (“ΔcspA/pCspAB31”), CspAPKo (“ΔcspA/pCspAPKo”), CspAZQ1 (“ΔcspA/pCspAZQ1”), or CspAB31L246D (“ΔcspA/pCspAB31L246D”), or B313
carrying the vector pBSV2G (“B313/Vector”, negative control) was incubated with serum from human, mouse, or horse with a final concentration of
20%. The bacteria were stained with a guinea pig anti-C3 polyclonal IgG, a mouse anti-C5b-9 monoclonal antibody aE11 (for spirochetes incubated
with human or horse serum), or a rabbit anti-C5b-9 polyclonal IgG (for spirochetes incubated with mouse serum) followed by an Alexa 647-conjugated
goat anti-guinea pig IgG or goat anti-mouse IgG, or goat anti-rabbit IgG prior to being applied to flow cytometry analysis. Representative histograms
of flow cytometry analysis showing the deposition levels of mouse (A) C3b or (C) MAC on the surface of indicated B. burgdorferi strains. The
deposition levels of (B) C3b or (D) MAC of indicated animals on the surface of B. burgdorferi were measured by flow cytometry and presented as mean
fluorescence index (MFI). Each bar represents the mean of three independent determinations ± SEM. Significant differences (P < 0.05 by one-way
ANOVA with post hoc Bonferroni correction) in the deposition levels of C3b or MAC relative to the B313/Vector (“”) or between two strains relative
to each other (“#”).
https://doi.org/10.1371/journal.ppat.1007106.g003
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CspAB31 or the FH-binding deficient point mutant CspAB31L246D. Although CspAB31 has also
been shown to bind complement C7 and C9, and plasminogen [24, 25, 43], CspAB31L246D
was selectively defective in FH-binding, but still bound to C7, C9, or plasminogen at levels
similar to CspAB31 (S1 Table and S6 Fig). Thus, the CspAB31L246D producing strain showed
significantly greater levels of C3 and MAC deposition than the strain producing CspAB31 (Fig
3B and 3D), suggesting that the FH-binding activity of CspA mediates inhibition of comple-
ment deposition on the surface of B. burgdorferi.
CspA-mediated FH-binding activity facilitates bacterial serum survival in a
host-specific fashion
The ability of pathogens to inhibit the host complement in the bloodstream correlates with
their ability to survive in the serum [7]. Thus, we sought to investigate how species-to-species
variation of CspA promotes bacterial survival in serum from different vertebrate hosts. We
incubated WT strain B31-5A15, as well as strain 5A4NP1ΔcspA-V or this plasmid encoding
cspAB31, cspAPKo, cspAZQ1, or cspAB31L246D with serum from human, horse, or quail and nega-
tive control serum (C3-depleted or heat treated human serum) for four hours. Mouse serum
was not used, as its complement is highly labile ex vivo [44], and the ability to kill spirochetes
in vitro has not been consistently observed [45, 46]. More than 75% of the strain B31-5A15 sur-
vived in human serum or serum without active complement (C3-depleted serum) (Fig 4A and
4B). In addition, this strain survived in horse and quail serum, with average spirochete serum
survival above 75% (Fig 4C and 4D). Less than 20% of the strain 5A4NP1ΔcspA-V remained
motile after incubation with human serum (less than the survival percentage of WT strain
B31-5A15, p< 0.05), but more than 85% of the strain 5A4NP1ΔcspA-V survived in the
C3-depleted or heat inactivated human serum (Fig 4A and 4B). Similarly, 5A4NP1ΔcspA-V
was killed by horse and quail serum, indicating that CspA plays an essential role in promoting
spirochete survival in not only human serum as shown previously [28], but also in horse and
quail serum (Fig 4C and 4D).
We also found that CspA variants produced on the strain 5A4NP1ΔcspA confer serum
survival in a host-specific manner: (1) More than 75% of motile cspAB31-complemented B.
burgdorferi were detected when incubated with sera from all these animals (Fig 4A, 4C and
4D). (2) A cspAPKo-complemented strain was able to survive in human serum (Fig 4A), but less
than 50% of the spirochetes survived when incubated with horse or quail sera (Fig 4C and 4D).
(3) Less than 20% of a cspAZQ1-complemented strain survived following the treatment
with human or horse serum (Fig 4A and 4C), but over 75% of this strain survived in quail
serum (Fig 4D). Additionally, less than 25% of cspAB31L246D-complemented strain remained
motile after treatments with human, horse, or quail serum, which was about three-fold lower
than the cspAB31-complemented strain (Fig 4A, 4C and 4D). Conversely, more than 75% of
cspAB31L246D-complemented strain survived in either C3-depleted or heat treated-serum, sug-
gesting that the FH-binding ability of CspA promotes spirochete survival in serum (Fig 4A to
4D).
B. burgdorferiCspA is up-regulated in post-molting but down-regulated in
post-feeding nymphal ticks
We and others have demonstrated the binding of FH to CspA in vitro and the role of CspA in
inactivating complement on spirochete surface and serum survival [25, 28, 30, 31] (Figs 2 to
4). How CspA promotes Lyme infection in vivo is still unclear. Thus, we examined regulation
of CspA throughout the enzootic cycle (S7B Fig). The naïve larval Ixodes scapularis ticks were
first allowed to feed on mice previously infected with the infectious B. burgdorferi strain B31-
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5A15. After the engorged and infected larval ticks molted into nymphal ticks, they were placed
on naïve C3H/HeN mice for blood feeding. We then determined the expression levels of spiro-
chete genes cspA, recA, and flaB in ticks and mouse tissues using quantitative RT-PCR and cal-
culated the expression levels of cspA and recA relative to that of flaB. recA expression levels
relative to flaB levels remained unchanged throughout the enzootic cycle (Fig 5A top panel).
As reported previously [26], cspA expression was detected in both larval and nymphal ticks, as
well as at tick bite sites on the mouse skin at 72 hours post feeding, but not in mouse tissues
after spirochetes disseminate (Fig 5A bottom panel). B. burgdorferi in flat nymphs expressed
more than 2-fold increased levels of cspA compared to levels prior to molting (replete larvae,
p< 0.05), but the spirochetes’ cspA expression was reduced approximately 2-fold in nymphs
following 24 hours of feeding, compared to expression levels in flat nymphs (Fig 5A bottom
panel, p< 0.05).
We next sought to investigate CspA production in different stages of ticks. A previous
study reported that the production of CspA could not be visually detected in spirochetes using
fluorescence microscopy when spirochetes are present in nymphs [47]. One possibility for this
Fig 4. CspA variants mediate distinct levels of spirochete survival in serum from different vertebrate animals. B. burgdorferi strain B31-5A15
(“B31-5A15”), B31-5A4NP1ΔcspA harboring the vector pBSV2G (“ΔcspA/Vector”), or this cspA mutant strain producing CspAB31 (“ΔcspA/pCspAB31”),
CspAPKo (“ΔcspA/pCspAPKo”), CspAZQ1 (“ΔcspA/pCspAZQ1”), or CspAB31L246D (“ΔcspA/pCspAB31L246D”) was incubated for four hours with
untreated (filled bars) or heat-inactivated (HI, hatched bars) serum with a final concentration of 40%. These sera include (A) human serum or
(B) C3-depleted human serum (Human C3- serum) or the serum from (C) horse or (D) quail. The number of motile spirochete was assessed
microscopically. The percentage of survival for those B. burgdorferi strains was calculated using the number of mobile spirochetes at four hours post
incubation normalized to that prior to the incubation with serum. Each bar represents the mean of three independent determinations ± SEM.
Significant differences (P< 0.05 by one-way ANOVA with post hoc Bonferroni correction) in the percentage survival of spirochetes relative to the
ΔcspA/Vector (“”) or between two strains relative to each other (“#”).
https://doi.org/10.1371/journal.ppat.1007106.g004
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Fig 5. B. burgdorferi expresses distinct levels of CspA at different stages of enzootic cycle. C3H/HeN mice were infected with 105 B. burgdorferi
strain B31-5A15. At 14 days post infection, the uninfected I. scapularis larval ticks were allowed to feed on these mice to repletion. After the replete
larvae molted into nymphs, these B. burgdorferi-infected nymphs were allowed to feed on naïve C3H/HeN mice for different period of time or to
repletion. The mice were euthanized at 7 or 14 days post feeding (“7dpf” or “14dpf”) to collect the inoculation site of skin (for mice at 7 and 14 days post
feeding), ears, tibiotarsus joints, bladder, and heart (for mice at 14 days post feeding). RNA was extracted from replete larvae (“larvae replete”), flat
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discrepancy is that visual detection using microscopy may be subjective and not be sensitive
enough to detect small differences in protein production [26]. We therefore gently lysed differ-
ent stages of ticks, sorted B. burgdorferi from the tick lysates by their granularity and size, and
quantitated the levels of CspA (and a constitutively produced protein FlaB) in the spirochetes
using flow cytometry (S8 Fig). The strain B313, which does not carry the plasmid encoding
cspA, was included as a negative control. There was no significant difference of FlaB produc-
tion by strain B31-5A15 and the negative control strain B313 cultured in vitro (Fig 5C top
panel). Additionally, we did not observe a significant difference of FlaB production by strain
B31-5A15 in different stages of ticks (Fig 5C top panel). In spirochetes cultured in vitro, CspA
production was detected in B31-5A15, but not in the strain B313 (Fig 5C bottom panel). Inter-
estingly, we were able to detect B. burgdorferi CspA production in all examined stages of the
ticks (significantly greater MFI values than strain B313; p< 0.05) (Fig 5C bottom panel). Fur-
ther, the CspA production more than quadrupled in flat nymphs compared to fed larvae
(p< 0.05), but thereafter halved after nymphs had fed for 24 hours (Fig 5B and 5C bottom
panel). Our findings on the spirochetes’ CspA protein production in ticks are consistent with
the dynamic changes of cspA mRNA levels (Fig 5A)[26], suggesting that CspA is up-regulated
after larval ticks molt but is down-regulated after nymphal ticks feed.
The in vitro FH-binding activity of CspA is correlated with spirochete
survival in nymphs and transmission to mice
We then examined the role of CspA to facilitate spirochete survival in the enzootic cycle. As
expected, when we inoculated C3H/HeN mice by subcutaneous needle infection with strain
5A4NP1ΔcspA-V or the WT strain B31-5A15 (S7A Fig), these strains colonized tissues to simi-
lar degrees (S9 Fig, 14 days post infection). Similarly, at early stages of infection, strain
5A4NP1ΔcspA-V colonized the skin of the mouse inoculation site and triggered bacteremia
with a burden similar to the WT strain B31-5A15 (S10 Fig, 4 days post infection). These results
indicate that CspA is not essential during early and disseminated stages of mouse infection
through needle inoculation.
WT strain B31-5A15 and the strain 5A4NP1ΔcspA-V display similar levels of infectivity at
14 days post needle infection in mice (S9 Fig). Thus, to examine whether CspA plays a role in
vivo during tick infection, we allowed the larval ticks to feed until replete on mice previously
infected for 14 days with either WT strain B31-5A15 or strain 5A4NP1ΔcspA-V (S7B Fig).
Nymphal ticks that developed after replete larval ticks molted were fed on naïve C3H/HeN
mice until removed or replete, and the bacterial burdens in the nymphs and nymph-infected
mouse blood and tissues were determined (S7B Fig). The bacterial loads of the strain
5A4NP1ΔcspA-V did not differ from the WT strain B31-5A15 in fed larvae or flat nymphs
nymphs (“nymph flat”), fed nymphs at 24 hours post feeding (“24hpf”) or replete nymphs (“nymph replete”) as well as in vitro cultured B. burgdorferi
strain B313 (“B313”, negative control) or B31-5A15 (“B31-5A15”, positive control) in BSKII medium. (A) RNA was also extracted from mouse tissues
including tick biting site (“inoc. site”), ears, tibiotarsus joints, bladder, and heart at 7 and/or 14 days post feeding. The extracted RNA was then used to
determine the expression levels of cspA and constitutive expressed genes flaB and recA using qRT-PCR (see Materials and methods). The expression
levels of (Top panel; negative control) recA and (Bottom panel) cspA are presented by normalizing the expression levels of flaB (negative control) (see
Materials and methods). Each bar represents the mean of five independent determinations ± SEM (“#”). Significant differences (P< 0.05 by one-way
ANOVA with post hoc Bonferroni correction) in the normalized expression levels of cspA between two conditions relative to each other. (B and C) The
bacteria isolated from ticks or in vitro cultured B. burgdorferi strains were applied to flow cytometry. (B) Representative histograms of flow cytometry
analysis showing the production levels of CspA in B. burgdorferi in the indicated environment. (C) The production of FlaB (Top panel; negative
control) and CspA (Bottom panel) are presented as “ΔMFI”, the mean fluorescence index obtained from each of these strains subtracting that obtained
from the strains stained only by the secondary antibody. Each bar represents the mean of three independent determinations ± SEM. Significant
differences (P < 0.05 by one-way ANOVA with post hoc Bonferroni correction) in the production of CspA relative to the B313 cultured in vitro (“”) or
between two conditions relative to each other (“#”).
https://doi.org/10.1371/journal.ppat.1007106.g005
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(Fig 6A and 6B). However, strain 5A4NP1ΔcspA-V did not survive in nymphs fed for 24, 48,
or 72 hours or in replete nymphs (approximately 1000-fold less than the WT strain, Fig 6C
and 6D and S11 Fig). Further, this strain was incapable of surviving in the mouse blood and
colonizing tissues at 7 and 14 days post nymph feeding (at least 40-fold less than the WT strain,
Fig 6E and 6F and S12 Fig). These results indicate that CspA enables the spirochete to survive
in fed nymphs, which subsequently permits spirochete transmission to mice.
We then investigated the ability of CspA variants to promote spirochete survival in infected
nymphs and in mice infected by tick infection. Mice were initially infected by needle injection
with the strain 5A4NP1ΔcspA producing CspAB31, CspAZQ1, or CspAPKo. All strains exhibited
similar levels of tissue colonization (S9 Fig). After the larval ticks fed on these mice and molted
into nymphs, the infected nymphs were placed on naïve mice (S7B Fig). All strains displayed
similar levels of survival in fed larvae and flat nymphs (Fig 6A and 6B). The isogenic strain pro-
ducing CspAB31 or CspAPko was able to survive in fed nymphs, colonize the mouse inoculation
site, and survive in blood at the levels at least 150-fold more than the strain 5A4NP1ΔcspA-V
(P< 0.05) (Fig 6C to 6F). Conversely (and similar to 5A4NP1ΔcspA-V), the isogenic strain
producing CspAZQ1 did not survive in nymphs fed for 24 hours or in replete nymphs and was
incapable of surviving in the mouse blood and colonizing tissues (p> 0.05, Fig 6C to 6F). We
then compared the burdens of the isogenic B. burgdorferi strain producing CspAB31 or the
point mutant CspAB31L246D at different stages of tick and mouse infection. Similar levels of
both strains were seen in fed larvae as well as in flat nymphs (Fig 6A and 6B). Interestingly,
no CspAB31L246D-producing isogenic spirochetes were detectable in fed nymphs or at
mouse inoculation site and in the bloodstream (similar strain 5A4NP1ΔcspA-V, p>0.05)
Fig 6. FH-binding ability of CspA promotes spirochete survival in nymphal ticks upon feeding. C3H/HeN mice were infected with 105 B.
burgdorferi strain B31-5A15 (“B31-5A15”), B31-5A4NP1ΔcspA harboring the vector pBSV2G (“ΔcspA/Vector”), or this cspA mutant strain producing
CspAB31 (“ΔcspA/pCspAB31”), CspAPKo (“ΔcspA/pCspAPKo”), CspAZQ1 (“ΔcspA/pCspAZQ1”), or CspAB31L246D (“ΔcspA/pCspAB31L246D”). At 14 days
post infection, the uninfected I. scapularis larval ticks were allowed to feed on each of these mice until they are replete. After the replete larvae molt into
nymphs, those B. burgdorferi-infected nymphs were allowed to feed on naïve C3H/HeN mice to repletion. The bacterial loads in the (A) replete larvae
(“larvae replete”), (B) flat nymphs (“nymph flat”), fed nymphs at (C) 24 hours post feeding (“nymph 24hpf”) or (D) replete nymphs (“nymph replete”),
or (E) the site where nymphal ticks fed (“inoc. site”) or (F) blood at 7 days post nymph feeding (“blood 7dpf”) were determined by qPCR. The bacterial
loads in mouse tissues or blood were normalized to 100 ng total DNA. Shown are the geometric mean of bacterial loads ± 95% confidence interval of six
ticks or mice per group. Significant differences (P< 0.05 by one-way ANOVA with post hoc Bonferroni correction) in the spirochete burdens relative
to the ΔcspA/Vector (“”) or between two strains relative to each other (“#”).
https://doi.org/10.1371/journal.ppat.1007106.g006
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(Fig 6C to 6F). These findings suggest that the in vitro FH-binding ability of CspA is correlated
with spirochete survival in fed nymphs and with subsequent transmission to the mammalian
host.
FH binding to CspA enables complement evasion to permit spirochete
survival in fed nymphal ticks and transmission to mammalian hosts
We have demonstrated that CspA is critical to promote spirochete survival in nymphal ticks in
the first 24 hours of feeding (Fig 6). At this time point, the small amount of blood and the
interstitial fluid that contain complement components enter nymphs’ midguts [48, 49]. The
fact that the majority of B. burgdorferi have been found in the tick midgut at this time point
(and is thus in contact with the host blood and interstitial fluid) [48, 50] led us to hypothesize
that CspA-mediated complement inactivation facilitates host complement evasion by spiro-
chetes in fed nymphs. Thus, we fed the nymphs infected with the WT strain B31-5A15 or the
strain 5A4NP1ΔcspA-V on a mouse strain deficient in C3, the central molecule of complement
required for opsonophagocytosis and formation of MAC (S7C Fig) [51]. WT BALB/c mice,
which the C3-deficient mice were back-crossed into, served as controls. The spirochete bur-
dens in the nymphs prior to and post feeding on mice were determined using qPCR. Consis-
tent with infection in C3H/HeN mice, strain 5A4NP1ΔcspA-V was undetectable in the
nymphs fed on WT BALB/c mice (Fig 7A and 7B, left panel) and at the bite site of the mouse
skin, or in the blood (Fig 7C and 7D, left panel). However, this strain survived in nymphs fed
on C3-deficient mice for 24 hours or to repletion at levels indistinguishable from the WT
strain B31-5A15 (p> 0.05, Fig 7A and 7B, right panel). Strain 5A4NP1ΔcspA-V was also
observed at bite sites and in the blood of C3-deficient mice at 7 days post nymph feeding (Fig
7C and 7D, right panel). These results suggest that CspA plays an essential role in evading the
complement present in fed nymphs and for tick-to-mammal transmission.
We then examined the ability of B. burgdorferi strain B31-5A4NP1ΔcspA complemented
with cspAB31, cspAZQ1, or cspAPKo to survive in nymphs fed on WT BALB/c or C3-deficient
mice. In agreement with findings using WT C3H/HeN mice, the cspAB31- or cspAPKo- but not
cspAZQ1-complemented B. burgdorferi was detectable in the nymphs fed on WT BALB/c mice
(Fig 7A and 7B, left panel) and at the bite sites of the skin and in blood of these mice (Fig 7C
and 7D, left panel). Interestingly, the strain 5A4NP1ΔcspA-complemented with each of these
three cspA alleles exhibited nearly identical bacterial levels in nymphs fed on C3-deficient mice
for 24 hours or to repletion (Fig 7A and 7B, right panel). These cspA-complemented strains
also colonized the tick bite sites and bloodstream at 7 days after the onset of nymph feeding at
levels similar to WT bacteria (Fig 7C and 7D, right panel). These results suggest that the CspA
variants differentially promote spirochete complement evasion in fed nymphs, which is
required for spirochete transmission from ticks to mammals.
Nymphs infected with the cspAB31- or cspAB31-L246D-complemented strain were also
allowed to feed on WT or C3-deficient BALB/c mice to test how FH binding by CspA pro-
motes complement evasion in fed nymphs and facilitates tick-to-mammal transmission. We
observed that the cspAB31L246D-complemented strain displayed approximately 5000-fold
lower burdens than the cspAB31-complemented strain in nymphs fed on BALB/c mice for 24
hours or to repletion (Fig 7A and 7B, left panel). Similar to C3H/HeN mice, the cspAB31L246D
strain was not detectable at the bite site or blood of BALB/c mice (Fig 7C and 7D, left panel).
However, this mutant strain was detected in nymphs fed on C3-deficient mice for 24 hours,
replete nymphs (Fig 7A and 7B, right panel), and at the bite sites and blood of C3 deficient
mice at 7 days post feeding at levels similar to the cspAB31-complemented strain (Fig 7C and
7D, right panel). Our findings thus strongly suggest that the in vitro FH-binding activity of
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Fig 7. CspA-mediated FH-binding activity facilitates spirochete evading complement present in fed nymphs resulting in nymph-to-mouse
transmission. C3H/HeN mice were infected with 105 B. burgdorferi strain B31-5A15 (“B31-5A15”), B31-5A4NP1ΔcspA harboring the vector pBSV2G
(“ΔcspA/Vector”), or this cspA mutant strain producing CspAB31 (“ΔcspA/pCspAB31”), CspAPKo (“ΔcspA/pCspAPKo”), CspAZQ1 (“ΔcspA/pCspAZQ1”), or
CspAB31L246D (“ΔcspA/pCspAB31L246D”). At 14 days post infection, the uninfected I. scapularis larval ticks were allowed to feed on each of these mice
until they are replete. After the replete larvae molt into nymphs, those B. burgdorferi-infected nymphs were allowed to feed on naïve BALB/c or BALB/c
C3-/- mice to repletion. The bacterial loads in the nymphs fed on BALB/c (Left panel) or BALB/c C3-/- (Right panel) for (A) 24 hours post feeding
(“24hpf”) or (B) replete nymphs (“replete”), or at (C) the site where nymphs fed (“inoc. site”) on mice or (D) mouse blood at 7 days post nymph feeding
(“7dpf”) were determined by qPCR. The bacterial loads in mouse tissues or blood were normalized to 100 ng total DNA. Shown are the geometric mean
of bacterial loads ± 95% confidence interval of six ticks or mice per group. Significant differences (P< 0.05 by one-way ANOVA with post hoc
Bonferroni correction) in the spirochete burdens relative to the ΔcspA/Vector (“”) or between two strains relative to each other (“#”).
https://doi.org/10.1371/journal.ppat.1007106.g007
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CspA is correlated with the ability of B. burgdorferi to evade mouse complement in fed
nymphs, which would promote spirochete survival in those ticks and facilitate transmission
from ticks to mammalian hosts.
Discussion
Each of the Lyme borreliae species has been associated with specific vertebrate host(s) [7, 52,
53]. This spirochete-host association has been correlated with the ability of B. burgdorferi to
survive in the blood (or serum) from the corresponding hosts [7, 54–56], but the mechanism
that drives this association is still unclear. An attractive hypothesis is that the spirochetes
exhibit host-specific immune evasion, which leads to the observed spirochete-host association.
This could be due to variable spirochete outer surface proteins that interact with components
of host complement in a host-specific manner. One such protein is CspA, which displays vari-
ant-to-variant differences in binding to human FH [25]. However, the recombinant CspA pro-
tein from B. burgdorferi strain B31 is incapable of binding to any other vertebrate animals’ FH,
when the FH has been subjected to SDS-PAGE followed by a far-western blot [57]. In contrast,
FH from the serum of multiple animals including human and mouse recognizes CspA variants
run on a similar blot [58, 59]. This discrepancy may be due to structural alternations of ani-
mals’ FH on SDS-PAGE and the following far-western blot [8, 22, 23]. Therefore, we further
verified the binding of CspA to FH from mouse, horse, and quail by demonstrating that the
CspA of three main Lyme borreliae (B. burgdorferi, B. afzelii, or B. garinii) bind to purified FH
in a host-specific manner. Additionally, we observed that the ability of different CspA variants
to bind to FH correlates with their ability to inhibit complement activation on the spirochete
surface and facilitate spirochete survival in serum in a host-specific manner. We found that
these correlations not only apply to human complement (consistent with a previous study
[28]) but also to complement of other animals. Further, the high-resolution structure of CspA
suggests the recombinant version of this protein forms a dimer [35]. Two FH-binding regions
have been localized on the central cleft of the CspA dimer and on the C-termini of this protein
including leucine-246 [34, 60]. By ectopically producing a CspA point mutant (CspA-L246D)
selectively lacking FH-binding ability on spirochetes, we further demonstrated that the CspA-
mediated FH-binding activity contributes to the inactivation of host complement and spiro-
chete survival in sera. Note that similar non-polar features of this position (leucine-246) of
CspAB31 and the equivalent location of other CspA variants (phenylalanine-237 of CspAPKo
and leucine-252 of CspAZQ1) suggests a possibility that this amino acid is critical for the FH-
binding activity of these variants (S1 Fig).
FH is polymorphic between humans and mice (61% amino acid identity) [13, 14]. However,
we have demonstrated a similar ability of CspA to bind to both human and mouse FH as well
as inhibit complement deposition of both human and mouse sera on the spirochete surface.
These findings imply that CspA plays a similar role in mouse and human during infections.
Thus, the murine model was selected to test the role of the CspA-mediated FH binding activ-
ity. In addition, we have demonstrated that spirochetes require CspA to survive in fed nymphs
during tick-to-mouse transmission. This result is consistent with the fact that cspA is uniquely
expressed when spirochetes are in fed nymphs [26]. In contrast, CspA was not essential for spi-
rochetes to be transferred from mouse to larvae or establish infection in mouse skin at early
stages of infection, even though cspA expression was detectable at these stages. This may be
due to the previous observation that other genes encoding functionally redundant FH-binding
proteins (e.g. cspZ, erpP, and erpA) are co-expressed with cspA in spirochetes at these stages
[26]. Unexpectedly, CspA was detected in spirochetes when spirochetes are in flat nymphs
even though this protein was not required for B. burgdorferi to survive in these ticks. One
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possibility is that spirochetes may need to maintain certain levels of CspA in preparation to
survive in the first 24 hours of feeding when the small amount of blood and interstitial fluid
containing complement components enter the ticks’ midgut. This possibility is supported by
the observations that a cspA deficient B. burgdorferi is eliminated from human serum within 1
hour [28], but a significant shift in gene expression is not detectable until the spirochetes are
treated with blood for 48 hours [61].
In addition to CspA, B. burgdorferi requires other proteins to promote persistent survival in
fed nymphs and to be transmitted to vertebrate animals [62–66]. Some of these proteins have
been thought to be important for nutrient acquisition and metabolism in ticks [62, 67–72],
while the functions of the other proteins are still unclear. Blood and interstitial fluid from ver-
tebrate hosts contain diverse innate immune defense mechanisms, including complement [9].
In fact, B. burgdorferi displays increased infectivity in C3-deficient mice, which lack the ability
to deposit opsonic C3 fragments or to generate the pore-forming MAC that can lyse spiro-
chetes [73, 74]. This finding suggests that spirochetes need to evade hosts’ complement to sur-
vive in vertebrate animals. Moreover, Rathinavelu et al. reported that the blood meals from
either WT or C3-deficient mice do not eliminate the WT B. burgdorferi in fed ticks [75], rais-
ing the possibility that spirochetes produce factors to facilitate the complement evasion in fed
ticks. In this study, we observed a clear correlation of CspA variants or mutants in their FH-
binding activity with their ability to promote spirochete survival in nymphs fed on WT mice
and tick-to-mouse transmission. Conversely, this correlation was not detectable when these
ticks fed on C3-deficient mice. These findings identify that CspA-mediated FH-binding activ-
ity is necessary for the spirochetes’ evasion of complement in fed nymphs and eventually to be
transmitted to mammalian hosts. It is noteworthy that Woodman et al. reported that FH-defi-
cient mice were susceptible to WT B. burgdorferi infection, leading to the conclusion that spi-
rochetes did not require FH-binding activity to evade mouse complement [74]. However, the
lack of the FH leads to the spontaneous complement activation and subsequent complement
consumption in these mice, rendering them functionally complement deficient [41]. Thus,
FH-deficient mice cannot be used to study the role of FH-binding microbial proteins in com-
plement evasion.
It is noteworthy that B. garinii ZQ1 was originally isolated from ticks [76]. Therefore, the
infectivity of this strain in vertebrate animals is still unclear. We found that variant to variant
differences of CspA-mediated FH-binding activity are correlated with these variants’ ability to
confer spirochete transmission from nymphs to mice. Particularly, the cspA-ZQ1-comple-
mented strain infected C3-deficient mice but not wild type mice via ticks. Thus, our observa-
tion of CspA-ZQ1 selectively binding to quail FH implies that this variant may promote
spirochete infectivity in quail by evading this animal’s complement. (Note that the comple-
ment among different avian hosts may vary. Thus, that one CspA variant promotes infectivity
in quail may not necessarily indicate that the same variant contributes to the infectivity in
other birds). More in-depth studies on avian hosts promoted by CspA-ZQ1 are warranted. In
this study, we demonstrated the molecular mechanisms by which CspA of B. burgdorferi facili-
tates complement evasion of spirochetes in fed nymphal ticks (Fig 8). The host-specific differ-
ences in FH-binding capabilities conferred by CspA variants illuminate the possibility of a
complement-driven host-specificity and selective transmission of Lyme disease spirochetes.
Materials and methods
Ethics statement
All mouse experiments were performed in strict accordance with all provisions of the Animal
Welfare Act, the Guide for the Care and Use of Laboratory Animals, and the PHS Policy on
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Humane Care and Use of Laboratory Animals. The protocol was approved by the Institutional
Animal Care and Use Committee (IACUC) of Wadsworth Center, New York State Depart-
ment of Health (Protocol docket number 16–451), and University of Massachusetts Medical
School (Protocol docket number 1930). All efforts were made to minimize animal suffering.
Mouse, tick, and bacterial strains
C3H/HeN, BALB/c and Swiss-Webster mice were purchased from Charles River (Boston,
MA) and Taconic (Hudson, NY), respectively. C3-/- mice (C57BL/6) purchased from Jackson
Laboratory (Bar Harbor, ME) were backcrossed for 11 generations into BALB/c background.
Mice were genotyped for the C3 allele by PCR analysis of mouse tail DNA. Ixodes scapularis
tick larvae were purchased from National Tick Research and Education Center, Oklahoma
State University (Stillwater, OK) or obtained from BEI Resources (Manassas, VA). B. burgdor-
feri-infected nymphs were generated as described in the section “Mouse infection experiments
by ticks.” The Borrelia and Escherichia coli strains used in this study are described in S2 Table.
E. coli strains DH5α, M15, and derivatives were grown in Luria-Bertani (BD Bioscience,
Franklin lakes, NJ) broth or agar, supplemented with kanamycin (50 μg/mL), ampicillin
(100 μg/mL), or no antibiotics where appropriate. All B. burgdorferi, B. afzelii, and B. garinii
strains were grown in BSK-II completed medium supplemented with kanamycin (200 μg/mL),
streptomycin (50 μg/mL), gentamicin (50 μg/mL), or no antibiotics (see S2 Table).
Generation of recombinant CspA proteins and antisera
The open reading frames lacking the putative signal sequences of bba68 (cspAB31) from B. burg-
dorferi strains B31 or zqa68 (cspAZQ1) from B. garinii strain ZQ1 were amplified using prim-
ers listed in S3 Table to generate recombinant histidine-tagged CspA proteins. In addition, an
Fig 8. A proposed model showing CspA-mediated FH-binding activity promotes spirochete evasion of complement in feeding nymphs to
facilitate tick-to-host transmission. CspA of spirochetes binds to FH present in the host’s blood and interstitial fluid in feeding nymphs to facilitate
spirochete escape from the complement-mediated killing. Such CspA-mediated immune evasion ultimately facilitates spirochete transmission from
nymphs to hosts.
https://doi.org/10.1371/journal.ppat.1007106.g008
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altered open reading frame encoding CspAB31L246D (residue 26 to 252 of CspAB31 with leu-
cine-246 replaced by aspartate) was amplified using the primers described in S3 Table. Ampli-
fied fragments were engineered to encode a BamHI site at the 5’ end and a stop codon
followed by a SalI site at the 3’ end. PCR products were sequentially digested with BamHI and
SalI and then inserted into the BamHI and SalI sites of pQE30Xa (Qiagen, Valencia, CA). The
plasmids were transformed into E. coli strain M15, and the plasmid inserts were sequenced
(Wadsworth ATGC core facility). The resulting M15 derived strains and the M15 strain carry-
ing the plasmid encoding the open reading frames lacking the putative signal sequences of
bafPKo_A0067 (cspAPKo) from B. afzelii strains PKo [25] were used to produce respective
recombinant CspA variants or mutants (S2 Table). The histidine-tagged CspA variants or
mutants were produced and purified by nickel affinity chromatography according to the man-
ufacturer’s instructions (Qiagen, Valencia, CA). Antisera against CspAB31, CspAPKo, or
CspAZQ1 were generated by immunizing four-week-old Swiss Webster mice with each of the
CspA proteins as described previously [77]. The ability of each of these antisera to recognize
CspAB31, CspAPKo, CspAZQ1, or CspAB31L246D was verified using ELISA. Basically, one
microgram of the above-mentioned CspA variants or mutant proteins, or BSA (negative con-
trol) was immobilized on microtiter plates (MaxiSorp, ThermoFisher). The antisera raised
from the mice immunized with each of these CspA variants (1: 1, 000x) were added to the
wells. The pre-immune mouse serum was also included as a negative control. HRP-conjugated
goat anti-mouse IgG (1: 1,000x) (ThermoFisher) was then added as antibody to detect the
binding of the mouse anti-sera to CspA variants. The plates were washed three times with
PBST (0.05% Tween 20 in PBS), and 100 μL of ortho-phenylenediamide dihydrochloride solu-
tion (Sigma-Aldrich) were added to each well and incubated for five minutes. The reaction
was stopped by adding 50 μL of 2.6M hydrosulfuric acid to each well. Plates were read at
405nm using a Tecan Sunrise Microplate reader (Tecan, Morrisville NC). The anti-sera of
CspAB31, CspAPKo, CspAZQ1, or CspAB31L246D exhibited similar levels of binding to each of
these CspA variants or mutant proteins (S13 Fig).
Circular Dichroism (CD) spectroscopy
CD analysis was performed on a Jasco 810 spectropolarimeter (Jasco Analytical Instrument,
Easton, MD) under nitrogen. CD spectra were measured at room temperature (RT, 25˚C) in a
1 mm path length quartz cell. Spectra of CspAB31 (10 μM) or CspAB31L246D (10 μM) were
recorded in phosphate based saline buffer (PBS) at RT, and three far-UV CD spectra were
recorded from 190 to 250 nm for far-UV CD in 1 nm increments. The background spectrum
of PBS without proteins was subtracted from the protein spectra. CD spectra were initially ana-
lyzed by the software Spectra Manager Program (Jasco). Analysis of spectra to extrapolate sec-
ondary structures and the prediction of the spectrum using the amino acid sequences of
CspAB31 were performed by Dichroweb (http://dichroweb.cryst.bbk.ac.uk/html/process.
shtml) using the K2D and Selcon 3 analysis programs [78].
Purification of horse and quail FH
The procedure to purify FH from serum of various vertebrate animals has been described pre-
viously [79]. Basically, the serum collected from horses originally from New Zealand, (Ther-
moFisher, Waltham, MA) or Coturnix coturnix quail (Canola Live Poultry Market, Brooklyn,
NY) was centrifuged to remove aggregates prior to being diluted with two volumes deionized
water. Then, 6g of cyanogen bromide (CNBr)-activated Sepharose 4B resin (GE Healthcare,
Piscataway, NJ) was mixed with 100mg of Trinitrophenyl-Bovine Serum Albumin (TNP-BSA)
(LGC Biosearch Technology, Petaluma, CA) for 2 hours followed by incubation with the
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blocking buffer (PBS with 100mM ethanolamine-HCl, 150mM NaCl at pH8.5) at room tem-
perature for 2 hours. The TNP-BSA CNBr resin was then equilibrated with PBS and packed
into a column. After the diluted serum was applied into the TNP-BSA CNBr column, the col-
umn was washed by PBS until the OD280 values of the effluent below 0.04 Arbitrary Unit.
Bound proteins were then eluted by the elution buffer (PBS with 0.5mM EDTA and 1M
sodium chloride at pH7.4). The eluent was subsequently applied to a NAb Protein G Spin Col-
umn (ThermoFisher) according to the manufacturer’s instruction to remove the immunoglob-
ulin in the serum. The purified factor H was confirmed by ELISA [77]. A sheep anti-FH
polyclonal IgG (ThermoFisher) (1:200x), which has been shown to recognize horse FH [58] or
a mouse anti-FH monoclonal antibody VIG8 (1: 200x), which has been observed to recognize
avian FH [80] was used as a primary antibody. A horse radish peroxidase (HRP) conjugated
donkey anti-sheep (1:2,000x) (ThermoFisher) or goat anti-mouse (1: 1,000x) was used as a sec-
ondary antibody.
FH binding assay by quantitative ELISA
Quantitative ELISA for FH, C7, C9, or plasminogen binding by CspA proteins was performed
similarly to that previously described [78]. For FH binding, one microgram of BSA (negative
control; Sigma-Aldrich) or FH from human (ComTech, Tyler, Texas), mouse (MyBiosource,
San Diego, CA)[81], horse, or quail was coated onto microtiter plate wells. For FH binding,
one hundred microliters of increasing concentrations (0.03125, 0.0625, 0.125, 0.25, 0.5, 1,
2 μM) of histidine-tagged DbpA from B. burgdorferi strain B31 (negative control) or a CspA
variant or mutant, including CspAB31, CspAPKo, CspAZQ1, or CspAB31L246D was then added
to the wells. Mouse anti-histidine tag (Sigma-Aldrich, St. Louis, MO; 1:200) and HRP-conju-
gated goat anti-mouse IgG (1: 1,000x) were used as primary and secondary antibodies, respec-
tively, to detect the binding of histidine-tagged proteins. The plates were washed three times
with PBST (0.05% Tween 20 in PBS), and 100 μL of tetramethyl benzidine (TMB) solution
(ThermoFisher) were added to each well and incubated for five minutes. The reaction was
stopped by adding 100 μL of 0.5% hydrosulfuric acid to each well. Plates were read at 405 nm
using a Tecan Sunrise Microplate reader. To determine the dissociation constant (KD), the
data were fitted by the following equation using GraphPad Prism software (Version 7, La Jolla,
CA).
OD405 ¼
OD405max½CspA proteins
KDþ ½CspA proteins
ð1Þ
Surface plasmon resonance (SPR)
Interactions of CspA with FH were analyzed by a SPR technique using a Biacore 3000 (GE
Healthcare). Ten micrograms of FH from human, mouse, or horse were conjugated to a CM5
chip (GE Healthcare) as described previously [78]. A control flow cell was injected with PBS
without FH. For quantitative SPR experiments to determine FH-binding, ten microliters of
increasing concentrations of CspA variants or mutants, including CspAB31, CspAPKo,
CspAZQ1, or CspAB31L246D, were injected into the control cell and flow cell immobilized with
different animals’ FH, human plasminogen (Sigma-Aldrich), C7 (ComTech), or C9 (Com-
Tech) at 10 μL/min, 25˚C. To obtain the kinetic parameters of the interaction, sensogram data
were fitted by means of BIAevaluation software version 3.0 (GE Healthcare), using the one
step biomolecular association reaction model (1:1 Langmuir model), resulting in optimum
mathematical fit with the lowest Chi-square values.
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Shuttle plasmid construction
cspAB31, cspAPKo, cspAZQ1, or cspAB31L246D was first PCR amplified with the addition of a SalI
site and a BamHI site at the 5’and 3’ ends, respectively, using Taq polymerase (Qiagen) and the
primers (see S3 Table) to generate the plasmids encoding cspA alleles. The unpaired nucleo-
tides at 5’ and 3’ end of the amplified DNA fragments were removed by exonuclease from Clo-
neJet PCR cloning kit (ThermoFisher) and then inserted into the vector pJET1.2/blunt
(ThermoFisher). The plasmids were then digested with SalI and BamHI to release the cspA
alleles, which were then inserted into the SalI and BamHI sites of pBSV2G (S2 Table) [82]. The
promoter region of cspA from B. burgdorferi B31, 400bp upstream from the start codon of
cspA, was also PCR amplified. SphI and SalI sites were added at the 5’and 3’ ends of amplified
DNA, respectively, using primers pcspAfp and pcspArp (S3 Table). Promoter fragments were
then inserted into the SphI and SalI sites of pBSV2G to drive the expression of cspAB31,
cspAPKo, cspAZQ1, and cspAB31L246D.
Plasmid transformation into B. burgdorferi
Electrocompetent B. burgdorferi B31-5A4NP1ΔcspA prepared as described [77, 83] was trans-
formed separately with 80 μg of each of the shuttle plasmids encoding cspAB31, cspAPKo,
cspAZQ1, or cspAB31L246D (S2 Table) and cultured in BSK II medium at 33˚C for 24 hours. Liq-
uid plating transformations were performed in the presence of antibiotic selection (50 μg/mL
gentamicin, 200μg/mL kanamycin, 50μg/mL streptomycin, as required), as described previ-
ously [84, 85]. After incubation at 33˚C in 5% CO2 for two weeks, kanamycin-, gentamicin-,
and streptomycin-resistant colonies of cspA-complemented B. burgdorferi were obtained and
expanded at 33˚C in liquid BSK II medium containing these antibiotics, followed by genomic
DNA preparation as previously described [86]. PCR was performed with primers (S3 Table)
specific for aphI (encoding the kanamycin resistance gene), aacC1 (encoding the gentamicin
resistance gene), and aadA (encoding the streptomycin resistance gene) to verify their pres-
ence in the transformants. The plasmid profiles of the cspA deficient mutant complemented
with cspA alleles were examined as described previously [36]. The plasmid profiles of these
strains were found to be identical to those of the parental strain 5A4NP1ΔcspA and the strain
5A4NP1ΔcspA-V.
Surface localization of CspA detected by flow cytometry
The determination of surface localization of CspA by Flow cytometry has been described pre-
viously [77, 87, 88]. Basically, 1 x 108 B. burgdorferi cells producing CspAB31, CspAPKo,
CspAZQ1, or CspAB31L246D were washed three times with HBSC buffer containing glucose
and BSA (25 mM Hepes acid, 150 mM sodium chloride, 1 mM MnCl2, 1 mM MgCl2, 0.25 mM
CaCl2, 0.1% glucose, and 0.2% BSA, final concentration) and then resuspended into 500 μL of
the same buffer. To prepare permeabilized spirochetes, 1 × 108 B. burgdorferi was incubated
with 100% methanol for an hour, followed by washing three times with HBSC buffer contain-
ing glucose and BSA. A mixture of mouse antisera raised against CspAB31, CspAPKo, or
CspAZQ1 or monoclonal mouse antibody against B. burgdorferi FlaB (negative control) was
used as a primary antibody (1:250x). An Alexa 647-conjugated goat anti-mouse IgG (Thermo-
Fisher) (1:250x) was used as a secondary antibody. Three hundred microliters of formalin
(0.1%) were then added for fixing. Surface production of CspA was measured by flow cytome-
try using a Becton-Dickinson FACSCalibur (BD Bioscience). All flow cytometry experiments
were performed within two days of collection of B. burgdorferi samples. Spirochetes in the sus-
pension were distinguished on the basis of their distinct light scattering properties in the flow
cytometer equipped with a 15 mW, 488 nm air-cooled argon laser, a standard three-color filter
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arrangement, and CELLQuest Software (BD Bioscience). The mean fluorescence index (MFI)
of each sample was obtained from FlowJo software (Three-star Inc, Ashland, OR) representing
the surface production of the indicated proteins. Mean Fluorescence Index (MFI) normalized
to that of CspA from permeabilized B. burgdorferi obtained from S5 Fig was used to compare
the surface production of CspA in different strains. These results represent the mean of three
independent determinations ± the standard deviation of mean. Each standard deviation of
mean value was no more than 7% of its mean value.
FH-binding assay of B. burgdorferidetected by flow cytometry
To quantitatively determine the ability of B. burgdorferi strains producing CspAB31, CspAPKo,
CspAZQ1, or CspAB31L246D in binding to FH, 1 x 10
7 B. burgdorferi strains were washed twice
by PBS, resuspended into 100μL of the same buffer, and then incubated with FH from human,
mouse, horse, or quail (1 μg per reaction) or C3-depleted human serum (ComTech) or serum
from BALB/c C3-/- mice (Final concentration: 20%) at 25˚C for 1 hour. Following incubation,
the spirochetes were washed three times with PBS and resuspended in 100μL of HBSC buffer
containing DB. A sheep anti-FH polyclonal IgG (ThermoFisher) (1:250x), which has been
shown to recognize FH from human, mouse and horse [58] or a mouse anti-FH monoclonal
antibody VIG8 (1:250x), which has been observed to recognize avian FH [80] were used as pri-
mary antibodies. An Alexa 647-conjugated donkey anti-sheep IgG (ThermoFisher) (1: 250x)
or goat anti-mouse IgG (1:250x) was used as secondary antibodies. Three hundred microliters
of formalin (0.1%) was then added for fixing. The mean fluorescence index (MFI) of each B.
burgdorferi strain was measured to determine the FH-binding capability promoted by CspA
variants or mutants using a Becton-Dickinson FACSCalibur and analyzed by FlowJo software
as described above.
C3b and MAC deposition assay on B. burgdorferidetected by flow
cytometry
The deposition of C3b and MAC on the surface of B. burgdorferi producing CspAB31, CspAPKo,
CspAZQ1, or CspAB31L246D was quantitatively determined by flow cytometry as revised from
previous reported methodologies [89]. B. burgdorferi strains were washed twice, resuspended
in PBS, and then incubated with serum from human (MP Biomedical, Santa Ana, CA), mouse
(Southern Biotech, Birmingham, AL), horse, or quail (Final concentration: 20%) at 25˚C for 1
hour. Twenty percent serum was used in this study because more than 80% of B. burgdorferi
strains were capable of surviving in this concentration of serum [28], but C3b and MAC have
been constantly detected on spirochete surface when these strains are incubated with 20%
serum [28]. Prior to being mixed with B. burgdorferi, those sera were screened with the C6
Lyme ELISA kit (Diamedix, Miami Lakes, FL) to determine whether the individual from
which it was collected had prior exposure to B. burgdorferi by detecting the antibody against
the C6 peptide of a B. burgdorferi protein VlsE [90]. Then, the spirochetes were washed three
times with PBS and resuspended in HBSC buffer containing glucose and BSA. A guinea pig
anti-C3 polyclonal IgG (ThermoFisher) (1:250x), which has been shown to recognize C3 from
human, mouse and horse, was used as a primary antibody to detect C3b. A mouse anti-C5b-9
monoclonal antibody aE11 (ThermoFisher) (1:250x), which has been observed to recognize
MAC from human and horse, and a rabbit anti-C5b-9 polyclonal IgG (Abcam, Cambridge,
MA) (1:250x), which has been verified to bind to MAC from human and mouse, were used as
primary antibodies. An Alexa 647-conjugated goat anti-guinea pig IgG (ThermoFisher)
(1:250x), goat anti-mouse IgG (ThermoFisher) (1:250x), or goat anti-rabbit IgG (Thermo-
Fisher) (1:250x) were used as secondary antibodies. Three hundred microliters of formalin
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(0.1%) were then added for fixing. The mean fluorescence index (MFI) of each B. burgdorferi
strain was measured to determine the levels of C3b or MAC deposition on the surface of B.
burgdorferi strains using a Becton-Dickinson FACSCalibur and analyzed by FlowJo software
as described above.
Serum sensitivity assay
The serum sensitivity of B. burgdorferi strain B31-5A15, B31-5A4NP1ΔcspA-V and this cspA
mutant strain producing CspAB31, CspAPKo, CspAZQ1, or CspAB31L246D was measured using
a published procedure [91]. Briefly, triplicate samples of each strain were grown to mid-log
phase and diluted to a final concentration of 5×106 bacteria per milliliter into BSKII medium
without rabbit serum with a final concentration of 40% normal serum from human, mouse,
horse, or quail or C3-depleted human serum. We also included the spirochetes mixed with
40% heat-inactivated serum from these vertebrate hosts, which was incubated at 55 ˚C for 2
hours prior to being mixed with spirochetes. At 0 and 4 hours after the addition of serum, an
aliquot was taken from each condition and counted by Petroff-Hausser counting chamber
(Hausser Scientific, Horsham, PA) using a Nikon Eclipse E600 darkfield microscope (Nikon,
Melville, NY). Though the strain B31-5A4NP1ΔcspA has been shown to be eliminated by incu-
bating human serum (final concentration 40%) in one hour [28], the survival of the B31-
5A4NP1ΔcspA-derived strains was evaluated at 4 hours post incubation to delineate the poten-
tial partial serum survival of these strains. The percentage of survival for those B. burgdorferi
strains was calculated using the number of mobile spirochetes at 4 hours post incubation nor-
malized to that prior to the incubation with serum.
Mouse infection experiments using needle inoculation
Four-week-old female C3H/HeN mice were used for experiments involved in needle infection
of B. burgdorferi. Mice were infected by intradermal injection as previously described [77] with
105 of different strains of B. burgdorferi strain B31-5A15, B31-5A4NP1ΔcspA-V or this cspA
mutant strain producing CspAB31, CspAPKo, CspAZQ1, or CspAB31L246D. The plasmid profiles
and the presence of the shuttle vector of each of these B. burgdorferi strains were verified prior
to infection as described to ensure the stability of the vector and no loss of plasmids (S7A and
S7B Fig) [36]. Mice were sacrificed at 14 days post-infection, the inoculation site of the skin,
the tibiotarsus joints, ears, bladder, and heart were collected to quantitatively evaluate levels of
colonization during infection.
Mouse infection experiments by ticks
The procedure of the tick infection has been shown in S7B and S7C Fig and described previ-
ously [92]. Basically, four-week-old male and female C3H/HeN mice were infected with 105 of
B. burgdorferi strain B31-5A15, the cspA knockout mutant strain B31-5A4NP1ΔcspA-V or this
cspA mutant strain producing CspAB31, CspAPKo, CspAZQ1, or CspAB31L246D by intradermal
injection as described above. The ear punches from those mice were collected and placed into
BSKII medium at 7 days post infection, and the spirochete growth in the medium was evalu-
ated to confirm the infection of these mice. At 14 days post infection, the uninfected larvae
were allowed to feed to repletion on those B. burgdorferi-infected C3H/HeN mice as described
previously [92]. Approximately 100 to 200 larvae were allowed to feed on each mouse. The
engorged larvae were collected and allowed to molt into nymphs in 4 to 6 weeks in a desiccator
at room temperature and 95% relative humidity in a room with light dark control (light to
dark, 12: 12 hours). DNA was extracted from engorged larvae and post molting flat nymphs to
examine the plasmid profiles and the presence of the shuttle vector the B. burgdorferi strains
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carried by these ticks as described to ensure no loss of plasmids during acquisition and molting
(S7B Fig) [36]. The flat nymphs molted from larvae were placed in a chamber on four to six-
week old male and female C3H/HeN, BALB/c, or C3-/- mice in BALB/c background as
described [93]. Ten nymphs were allowed to feed on each mouse. After the nymphs were forc-
ibly removed by forceps at 24, 48, or 72 hours post feeding, the rest of the ticks were allowed to
feed to repletion. The mice were then euthanized at 7 or 14 days after tick feeding, and the
blood, the feeding site of the skin, the tibiotarsus joints, bladder, ears, and heart were collected.
Quantification of cspA expression levels using quantitative RT-PCR
The B. burgdorferi strain B31-5A15, ticks, or mouse tissues were mixed with glass beads and
then homogenized by a Precellys 24 High-Powered Bead Mill Homogenizer (Bertin, Rockville,
MD). RNA was extracted from these homogenized bacteria, ticks or tissue samples using
Direct-Zol RNA MiniPrep Plus Kit (Zymo Research, Irvine, CA) according to the manufactur-
er’s instructions. Contaminating DNA was removed using RQ1 RNase-Free DNase (Promega,
Madison, WI) following vendor’s instruction. cDNA was synthesized from 1 μg of RNA mea-
sured by spectrophotometer using a qScript cDNA SuperMix (Quanta Bioscience, Beverly,
MA) according to the manufacturer’s instructions. Then, the quantification of cspA, flaB, or
recA expression from cDNA was performed using an Applied Biosystems 7500 Real-Time
PCR system (ThermoFisher) in conjunction with PowerUp SYBR Green Master Mix (Ther-
moFisher), based on amplification of the B. burgdorferi cspA, flaB, or recA gene using primers
BBCspAfp and BBCspArp (for cspA), BBFlaBfp and BBFlaBrp (for flaB), or BBRecAfp and
BBRecArp (for recA) as described previously [94] (S3 Table), respectively. Cycling parameters
for SYBR green-based reactions were 50˚C for 2 minutes, 95˚C for 10 minutes, 45 cycles of
95˚C for 15 seconds, and 60˚C for 1 minute. Melting curve analysis for purity was performed
on each sample by performing 80 cycles of increasing temperature for 10 seconds, each begin-
ning at 55˚C. Three biological replicates were included. Each biological replicate was run in
duplicates and checked for intra-run variation. The gene expression of cspA or recA was nor-
malized to that of flaB using the ΔCT method, where the relative expression of target (cspA or
recA), normalized to the expression of flaB, is given by 2−ΔCT, where Ct is the cycle number of
the detection threshold (see Eq 2). All analyses and calculations were performed using the
Applied Biosystem sequence detection software version 7.5.1 (ThermoFisher).
Relative cspA or recA expression to flab ¼ 2  ðCtðflaBÞ  CtðcspA or recAÞÞ ð2Þ
Determination of CspA production levels of B. burgdorferi in ticks using
flow cytometry
Ticks mixed with Enzyme Free cell dissociation buffer (ThermoFisher) were gently disrupted
by pipette tips and then incubated at 37˚C for 30 minutes to release the spirochetes into the
buffer. The ticks-spirochetes mixtures were subsequently spun down, washed by PBS, and
permeabilized by incubating the mixture with 100% methanol for one hour. After these mix-
tures were washed three times with HBSC buffer containing glucose and BSA, they were
incubated with mouse antisera raised against CspAB31 (1:250x) or monoclonal mouse anti-
body against FlaB (1:250x) as primary antibody followed by an Alexa 647-conjugated goat
anti-mouse IgG (1:250x) as a secondary antibody. Three hundred microliters of formalin
(0.1%) were then added for fixing. The spirochetes were first sorted using a FACSAria cell
sorter II equipped with FACSDiva software (BD Bioscience). The purity of sorted popula-
tions was greater than 70% in all experiments (S8 Fig). Then, the production of CspA and
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FlaB (negative control) in these spirochetes was measured by this equipment and software.
The mean fluorescence index (MFI) of each sample was obtained from FlowJo software rep-
resenting the production of the indicated proteins. The “ΔMFI” values are the mean fluores-
cence index obtained from each of these strains subtracting that obtained from the strains
stained only by the secondary antibody. The production levels of CspA and FlaB in different
stages of the enzootic cycle and in vitro cultured B. burgdorferi were presented as “ΔMFI” (Fig
5C). These results represent the mean of three independent determinations ± the standard
deviation of mean.
Quantification of B. burgdorferi in infected ticks, tissues and blood samples
The ticks collected from the chambers on the mice were mixed with glass beads and then
homogenized by a Precellys 24 High-Powered Bead Mill Homogenizer (Bertin, Rockville,
MD). The DNA from mouse tissues or blood or homogenized ticks was extracted using the
EZ-10 Genomic DNA kit (for mouse tissues and blood, Biobasic, Amherst, New York) or the
insect DNA kit (for ticks, OMEGA Biotek, Norcross, GA). The quantity and quality of DNA
for each tissue sample have been assessed by measuring the concentration of DNA and the
ratio of the UV absorption at 280 to 260 using a nanodrop 1000 UV/Vis spectrophotometer
(ThermoFisher). The amount of DNA used in this study was 100 ng for each sample, and the
280:260 ratio was between 1.75 to 1.85, indicating the lack of contaminating RNA or proteins.
Quantitative PCR (qPCR) was then performed to quantitate bacterial loads, using 100 ng of
DNA per reaction. B. burgdorferi genomic equivalents were calculated using an Applied Bio-
systems 7500 Real-Time PCR system (ThermoFisher) in conjunction with PowerUp SYBR
Green Master Mix (ThermoFisher), based on amplification of the B. burgdorferi recA gene
using primers BBRecAfp and BBRecArp (S3 Table), as described previously [77]. Cycling
parameters for SYBR green-based reactions were 50˚C for 2 minutes, 95˚C for 10 minutes, 45
cycles of 95˚C for 15 seconds, and 60˚C for 1 minute. The number of recA copies was calcu-
lated by establishing a threshold cycle (Ct) standard curve of a known number of recA gene
extracted from B. burgdorferi strain B31, then comparing the Ct values of the experimental
samples. To determine that the shuttle vectors expressing CspA variants is not missing during
tick-mouse studies, the colE1 gene on the shuttle vector was amplified using primers BBCo-
lE1fp and BBColE1rp (S3 Table) and the same cycling parameters used to amplify recA
described above. The bacterial burdens determined using colE1 primers were compared with
the burdens obtained using primers to amplify the recA gene, the gene on the chromosome of
spirochetes. The shuttle vectors were not missing as the bacterial loads determined using colE1
primers is close to 100% of the bacterial loads determined using recA primers. To assure the
low signals were not simply a function of the presence of PCR inhibitors in the DNA prepara-
tion, we subjected 5 samples from blood, tibiotarsus joints, and bladder of the mice infected by
B. burgdorferi strain B31-5A15, B31-5A4NP1ΔcspA-V or this cspA mutant strain producing
CspAB31, CspAPKo, CspAZQ1, or CspAB31L246D to qPCR using mouse nidogen primers
mNidfp and mNidrp (S3 Table) as an internal standard [77]. As predicted, we detected 107
copies of the nidogen gene from 100ng of each DNA sample, ruling out the presence of PCR
inhibitors in these samples.
Statistical analysis
Significant differences between samples were determined using Student’s T test or the one-
way ANOVA with post hoc Bonferroni correction. P-values were determined for each sample.
A P-value < 0.05 () or (#) was considered to be significant.
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Supporting information
S1 Fig. Sequence alignment of CspA variants from B. burgdorferi sensu lato. The amino
acid sequences of CspA variants from B. burgdorferi strains B31 (Bburg_B31_BBA68) and
ZS7 (Bburg_ZS7_A59), B. afzelii strains MMS (Bafz_MMS_MMSA71) and PKo (Bafz_P-
Ko_A0067), B. garinii strain ZQ1 (Bgar_ZQ1_ZQA68), B. bavariensis strain PBi (Bbav_P-
Bi_BGA66), and B. spielmanii strain A14S (Bspiel_A14S_A0067) were aligned using M-Coffee
with default parameters. Black shaded residues are identical among all of these variants. The
red asterisk indicates the leucine-246 of CspAB31, which is required for human, mouse, horse,
and quail FH-binding activity of this protein.
(TIF)
S2 Fig. Recombinant CspA variants or mutants display variable binding ability to FH from
different vertebrate animals by ELISA. The indicated concentrations of various recombinant
histidine-tagged CspAB31 (“B31”), CspAPKo (“PKo”), CspAZQ1 (“ZQ1”), CspAB31L246D
(“L246D”), or DbpA (“DbpA”, negative control) were added to triplicate wells coated with FH
from (A) human, (B) mouse, (C) horse, or (D) quail, and protein binding was quantitated by
ELISA. The experiments were performed on three independent occasions; within each occa-
sion, samples were run in duplicate. All experiments were performed with a single preparation
of recombinant proteins. Shown is a representative experiment from the average of two repli-
cates. The KD values (Table 1) representing the FH-binding affinity of each protein were deter-
mined from the average of three experiments.
(TIF)
S3 Fig. Recombinant CspA variants or mutants exhibit variable binding ability to FH from
different vertebrate animals by SPR. Ten micrograms of FH from (A to C) human, (D to F)
mouse, or (G and H) horse were conjugated on a SPR chip, resulting the response unit (RU)
as 563, 511, and 433 for human, mouse, and horse FH, respectively. Different concentrations
(0.125 to 2 or 4μM) of histidine tagged CspAB31 (“B31”), CspAPKo (“PKo”), CspAZQ1 (“ZQ1”),
or CspAB31L246D (“L246D”) were flowed over a surface of the chip. Binding was measured in
response units (RU) by SPR (see Materials and methods). The experiments were performed on
three independent occasions; within each occasion, samples were run in duplicate. All experi-
ments were performed with a single preparation of recombinant proteins. The kon, koff, and
KD values (Table 1) were determined from the average of these three experiments. Panel A, D,
and F are representative experiments applying 1 μM of indicated CspA proteins to the chip
coated with FH from indicated species.
(TIF)
S4 Fig. The mutation of leucine-246 to aspartate of CspAB31 does not affect its structure.
Far-UV CD analysis of CspAB31 and CspAB31L246D. The molar ellipticity, F, was measured
from 190 to 250 nm for 10μM of each protein in PBS. The predicted spectrum of CspAB31 was
generated applying the full-length amino acid sequences of this protein to DichroWeb (http://
dichroweb.cryst.bbk.ac.uk/html/links.shtml).
(TIF)
S5 Fig. CspA variants differ in their ability to confer spirochete binding to FH from
C3-depleted human or mouse serum. B. burgdorferi strain B31-5A15 (“B31-5A15”), B31-
5A4NP1ΔcspA harboring the vector pBSV2G (“ΔcspA/Vector”), or this cspA mutant strain pro-
ducing CspAB31 (“ΔcspA/pCspAB31”), CspAPKo (“ΔcspA/pCspAPKo”), CspAZQ1 (“ΔcspA/
pCspAZQ1”), or CspAB31L246D (“ΔcspA/pCspAB31L246D”), or B313 carrying the vector
pBSV2G (“B313/Vector”, negative control) was incubated with C3-depleted human or mouse
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serum. The bacteria were stained with a sheep anti-FH polyclonal IgG followed by an Alexa
647-conjugated donkey anti-sheep IgG prior to being applied to flow cytometry analysis. (Left
panel) Representative histograms of flow cytometry analysis showing the levels of FH from
(A) human or (B) mouse binding to indicated B. burgdorferi strains. (Right panel) The levels
of B. burgdorferi binding to FH from (A) human or (B) mouse were measured by flow cytome-
try and presented as mean fluorescence index (MFI). Each bar represents the mean of three
independent determinations ± SEM. Significant differences (P < 0.05 by one-way ANOVA
with post hoc Bonferroni correction) in the levels of FH binding relative to the B313/Vector
(“”) or between two strains relative to each other (“#”).
(TIF)
S6 Fig. The mutation of leucine-246 to aspartate of CspAB31 does not affect its ability in
binding to C7, C9, or plasminogen. Ten micrograms of human (A and B) C7, (C and D) C9,
or (E and F) plasminogen (PLG) were conjugated on a SPR chip, resulting the response unit
(RU) as 2823, 2034, and 2106 for C7, C9, and PLG, respectively. Different concentrations
(0.0625 to 1 μM) of histidine tagged (A, C, and E) CspAB31 (“B31”) or (B, D and F)
CspAB31L246D (“L246D”) were flowed over the chip. Binding was measured in RU by SPR
(see Materials and methods). The experiments were performed on three independent occa-
sions; within each occasion, samples were run in duplicate. All experiments were performed
with a single preparation of recombinant proteins. The kon, koff, and KD values (S1 Table) were
determined from the average of these three experiments.
(TIF)
S7 Fig. Summary of experimental design using a mouse model to test the role of CspA in
the enzootic cycle. Experimental infection of (A) C3H/HeN mice using needle infection (B)
C3H/HeN mice or (C) BALB/c or BALB/c C3-/- mice by larvae acquisition and nymph trans-
mission.
(TIF)
S8 Fig. FACS sorting of B. burgdorferi from ticks. I. scapularis ticks carrying B. burgdorferi
strain B31-5A15 were disrupted by pipette tips followed by incubation with enzyme free cell
dissociation buffer. The resulting suspensions were subjected to FACS to isolate B. burgdorferi.
To enhance the sorting efficiency, the spirochetes were permeabilized by methanol and then
stained by a mouse monoclonal antibody against B. burgdorferi flagellin (FlaB) followed by
Alexa 647 conjugated antibody against mouse IgG. Shown is the FACS data from gating for B.
burgdorferi in the suspensions of disrupted nymphal ticks at 24 hours post fed on naïve C3H/
HeN mice. (A) To discriminate between B. burgdorferi and debris of ticks or aggregations, the
B. burgdorferi-tick suspensions were introduced into FACS and plotted by forward scattering
(FSC) or side scattering (SSC). Two populations with distinct FSC and SSC (R1 and R2) were
sorted. (B) The populations of R1 and R2 from panel A were examined for their fluorescence
intensity of Alexa 647. The majority of the cells in R1 was Alexa 647 positive whereas the popu-
lation in R2 was Alexa 647 negative, suggesting B. burgdorferi was sorted at R1. (C) The same
disrupted ticks-B. burgdorferi suspensions were also permeabilized and then stained by Alexa
647 conjugated antibody against mouse IgG but not antibody against B. burgdorferi flagellin
(FlaB) to detect the background staining. The same populations of R1 and R2 were also gated.
(D) Both R1 and R2 from panel C were Alexa 647 negative, indicating low levels of back-
ground staining for each of these two populations. The (E) pre- and (F) post-sorted cells were
also imaged under a dark-field microscope (40x, bar = 5μm). The arrows indicate B. burgdor-
feri spirochetes.
(TIF)
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S9 Fig. The isogenic B. burgdorferi strain producing no CspA or each of the CspA variants
colonizes distal mammalian tissues at similar levels as WT strain during needle infection.
C3H/HeN mice were infected by needles with 105 B. burgdorferi strains B31-5A15 (“B31-
5A15”), B31-5A4NP1ΔcspA harboring the vector pBSV2G (“ΔcspA/Vector”), or this cspA
mutant strain producing CspAB31 (“ΔcspA/pCspAB31”), CspAPKo (“ΔcspA/pCspAPKo”),
CspAZQ1 (“ΔcspA/pCspAZQ1”), or CspAB31L246D (“ΔcspA/pCspAB31L246D”). At 14 days post
infection, the bacterial loads in (A) the inoculation site of skin (“inoc. Site”), (B) tibiotarsus
joints, (C) heart, (D) bladder, and (E) ears were determined by qPCR and normalized to 100
ng total DNA. Shown are the geometric mean of bacterial loads ± 95% confidence interval of 5
mice per group. No Significant differences (P> 0.05 by one-way ANOVA with post hoc Bon-
ferroni correction) of bacterial burdens was observed in these tissues from the mice infected
by each of those B. burgdorferi strains.
(TIF)
S10 Fig. Needle inoculation of a cspA deficient or WT B. burgdorferi results in similar levels
of tissue colonization and bacteremia at early stages of infection. C3H/HeN mice were
infected via needles with 105 B. burgdorferi strains B31-5A15 (“5A15”) or B31-5A4NP1ΔcspA
harboring the vector pBSV2G (“5A4NP1ΔcspA/Vector”). At 4 days post infection (“4dpi”), the
bacterial loads in the inoculation site of skin (“Inoc. Site”) and blood were determined by
qPCR and normalized to 100 ng total DNA. Shown are the geometric mean of bacterial
loads ± 95% confidence interval of 5 mice per group. No Significant differences (P> 0.05 by
Student’s t test) of bacterial burdens were observed from the mice infected between these B.
burgdorferi strains.
(TIF)
S11 Fig. A cspA-deficient B. burgdorferi is cleared in fed nymphs at 48 and 72 hours post
feeding. The nymphs infected with B. burgdorferi strain B31-5A15 (“5A15”) or a cspA mutant
strain B31-5A4NP1ΔcspA harboring the vector pBSV2G (“5A4NP1ΔcspA/Vector”) were
allowed to feed on C3H/HeN mice for 48 and 72 hours (“48hpf” and “72hpf”). Bacterial loads
in those fed nymphs were determined by qPCR. Shown are the geometric mean of bacterial
loads ± 95% confidence interval of four nymphs (for nymphs carrying strain B31-5A15) or five
nymphs (for nymphs carrying the strain B31-5A4NP1ΔcspA harboring the vector) per group.
“” indicates statistically (P< 0.05 by Student’s t test) different between two different strains-
infected nymphs.
(TIF)
S12 Fig. A cspA deficient B. burgdorferi is incapable of colonizing distal mammalian tissues
after the infection by nymphal ticks. C3H/HeN mice were infected by needles with 105 B.
burgdorferi strain B31-5A15 (“5A15”) or B31-5A4NP1ΔcspA harboring the vector pBSV2G
(“5A4NP1ΔcspA/Vector”). At 14 days post infection, the uninfected I. scapularis larval ticks
were allowed to feed on each of these mice to repletion. After the replete larvae molt into
nymphs, those B. burgdorferi-infected nymphs were allowed to feed on naïve C3H/HeN mice
to repletion. At 14 days after nymphal tick feeding (“14dpf”), the bacterial loads in the inocula-
tion site of skin (“inno. site”), tibiotarsus and knee joints, bladder, and heart were determined
by qPCR and normalized to 100 ng total DNA. Shown are the geometric mean of bacterial
loads ± 95% confidence interval of four mice per group. Significant differences (P< 0.05, Stu-
dent’s t test) in the spirochete burdens between two strains relative to each other (“”).
(TIF)
S13 Fig. The antisera of CspAB31, CspAPKo, CspAZQ1, CspAB31L246D recognize each of
these CspA variants or mutant proteins at indistinguishable levels. One microgram of
Role of CspA-mediated complement evasion in fed nymphs and transmission
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007106 May 29, 2018 28 / 35
CspAB31, CspAPKo, CspAZQ1, or CspAB31L246D, or BSA (as a negative control) was coated on
triplicate wells in a microtiter plate. The anti-sera raised against (A) CspAB31 (“αCspAB31”),
(B) CspAPKo (“αCspAPKo”), (C) CspAZQ1 (“αCspAZQ1”) or (D) pre-immune serum (“Preim-
mune”, negative control) were added to these wells. Bound antibody was measured by ELISA
(see Materials and methods), and the mean OD405 values ± standard deviations were deter-
mined. Asterisk (“”) indicates significant different levels of recognition by particular anti-sera
to CspA proteins (P< 0.05) compared that to BSA determined by one-way ANOVA with post
hoc Bonferroni correction.
(TIF)
S1 Table. CspAB31 and CspAB31L246D display indistinguishable affinity in binding to
C7, C9 and plasminogen.
(PDF)
S2 Table. B. burgdorferi strains and DNA plasmids used in this study.
(PDF)
S3 Table. Primers used in this study.
(PDF)
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